Fundraising Fox
Aethl Bio
Pittsburgh, US · Founded 2025 · Delaware corporation
Find your way into Aethl Bio
Sign up to see every warm intro you have to Aethl Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aethl Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aethl Bio is a biotech company developing wound care solutions focused on functional healing and restored skin integrity for patients with chronic wounds. Its work targets non-healing wounds such as diabetic foot ulcers, aiming to reduce recurrence, complications, and long-term care burden across the healthcare system.
Founders & leadership
MT
Melissa ThompsonExecutive
CR
Carmelo R. MontalvoChief Executive OfficerCarmelo Montalvo is the founder and CEO of Aethl Bio, a biotech company developing wound care solutions for chronic wounds. He previously co-founded Forest Devices, which developed an electronically-determined stroke screening device for emergency medical services.
Board
ZR
Zachary RichertBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 round · 2025
▶$1.6MraisedApr 2026 · 8 investors · BiotechnologyRule 506(b)
▶$1.6MraisedApr 2026 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Zachary RichertDirector
- Melissa ThompsonExecutive Officer
- Carmelo MontalvoExecutive Officer, Director
- Dan WillisExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.6M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Aethl Bio do?
- Aethl Bio is a biotech company developing wound care solutions focused on functional healing and restored skin integrity for patients with chronic wounds. Its work targets non-healing wounds such as diabetic foot ulcers, aiming to reduce recurrence, complications, and long-term care burden across the healthcare system.
- How much funding has Aethl Bio raised?
- Aethl Bio has disclosed $1.6M raised across 1 round.
- Where is Aethl Bio headquartered?
- Aethl Bio is headquartered in Pittsburgh, US.